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Abstract 
Purpose: To investigate the anti-inflammatory effects of kaempferol, myricetin, fisetin and ibuprofen in 
rat pups. 
Methods: The expression levels of cyclooxygenase (COX)-1, COX-2 and tumour necrosis factor-α 
(TNF-α) were determined by western blotting; the inhibition of these proteins by plant compounds was 
evaluated. In addition, a computational simulation of the molecular interactions of the compounds at the 
active sites of the proteins was performed using a molecular docking approach. Absorption, distribution, 
metabolism and excretion (ADME) and toxicity analysis of the plant compounds was also performed. 
Results: Kaempferol, myricetin and fisetin inhibited the activities of COX-1, COX-2 and TNF-α by 70–88 
%. The computational simulation revealed the molecular interactions of these compounds at the active 
sites of COX-1, COX-2 and TNF-α. ADME and toxicity analysis demonstrated that the three plant 
compounds were safe. 
Conclusion: The data obtained indicate that myricetin, kaempferol and fisetin exert anti-inflammatory 
effects in neonatal rats, with fewer side effects than those of ibuprofen. 
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Non-steroidal anti-inflammatory drugs (NSAIDs) 
exert anti-inflammatory effects, including 
analgesic and antipyretic effects. NSAIDs are the 
drugs most frequently administered by 
physicians, despite their potential to cause 
serious gastrointestinal complications [1, 2]. The 
term non-steroidal differentiates these drugs from 
steroids, which also exert anti-inflammatory 
effects. NSAIDs are non-narcotic and sometimes 
prescribed as a non-addictive substitute for 
narcotics. The activities of cyclooxygenase 
(COX)-1 and COX-2 are inhibited by NSAIDs, 
which in turn stabilises synthesis of 
prostaglandins and thromboxanes [3]. COX-1 
and COX-2 were characterized by Vane et al. [4]. 
Inhibition of COX-2 leads to anti-inflammatory 
and analgesic effects, and inhibition of COX-1 by 
NSAIDs such as aspirin causes gastrointestinal 
bleeding and ulcers. These enzymes also play 
an important role in the inflammatory cascade, as 
described by Simmons et al [5]. In addition, 
COX-1 and COX-2 have similar catalytic 
activities and structures; however, they are 
encoded by different genes and differ in their 
tissue distribution and role in transcriptional 
regulation [6-8]. The objective of this study was 
to investigate the anti-inflammatory effects of the 
plant compounds kaempferol, myricetin and 
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fisetin together with the NSAID ibuprofen, in 
neonatal rats. Kaempferol, myricetin, fisetin and 
ibuprofen were administered parenterally to rat 
pups to induce neuro-inflammation, and the 
inhibitory effects of these compounds on COX-1, 
COX-2 and TNF-α were examined [9]. The 
neuro-inflammatory response of the 
hippocampus and the inhibitory effects of 
kaempferol, myricetin, fisetin and ibuprofen on 
COX-1, COX-2 and TNF-α expression were 
assessed by western blotting [10]. Further, the 
molecular interactions of the plant compounds 
with the abovementioned enzymes were 




Chemicals and drugs 
 
Kaempferol, myricetin and fisetin were 
purchased from ABI Chem (Germany). Ibuprofen 
was purchased from Sigma-Aldrich (St. Louis, 
MO, USA). Triton X-100, NaCl, sodium dodecyl 
sulphate (SDS) and ethylenediamine tetraacetic 





All experiments were carried out in compliance 
with the National Institutes of Health guidelines 
[11] for the use of experimental animals, and the 
study protocol was approved by the local ethics 
committee of Zhumadian Central Hospital, 
Zhumadian, Henan Province, China (Reference 
No. ZCH/F-2015-Animal_Experiments-011A).  All 
efforts were made to minimise animal suffering 
and to reduce the number of animals used. 
Pregnant rats were housed in individual cages at 
an ambient temperature of 23 °C and moisture 
level of 50 % with ad libitum access to water and 
laboratory feed. The experiment began 24 h after 




Rat pups of both sexes were randomly assigned 
to five groups (n = 5 per group). Throughout the 
experiment, rat pups were kept in standard 
cages together with the nursing mother rat in 
room air. The humidity was maintained at 50 %, 
and the environmental temperature was 
maintained at 24 oC. The rat pups (Table 1) were 
administered kaempferol, myricetin, fisetin and 
ibuprofen (5 mg/kg) intracerebroventricularly 
(ICV). 
 
This administration route bypasses the 
blood‒brain barrier and other mechanisms that 
limit drug accessibility to the brain, allowing 
drugs to reach the central compartment at high 
concentrations. The survival and body weight of 
rat pups in each group were monitored daily 
throughout the experiment, and the animals were 
euthanised after 15 days. 
 









KMP Kaempferol 5mg/kg 
MYN Myricetin 5 mg/kg 
FSN Fisetin 5mg/kg 
IBF Ibuprofen 5 mg/kg 
CTL Control (sterile saline) 1 % 
 
Evaluation of anti-inflammatory activity 
 
Rat pups were sacrificed painlessly by cervical 
translocation. The head region was dissected 
and the brain removed from the skull. The tissue 
region of the hippocampus was removed from 
each hemisphere, treated with liquid nitrogen and 
stored at −80 °C. The hippocampal homogenates 
were subjected to western blotting to determine 
TNF-α, COX-1 and COX-2 protein levels. 
Homogenised hippocampal tissue was lysed in 
ice-cold lysis buffer comprising 50 mM Tris-HCl, 
0.1 % Triton X-100, 140 mM NaCl, 0.1 % SDS, 
0.30 % sodium deoxycholate, 1 mM EDTA and 1 
% protease inhibitor by passing the tissue 
through a 23-gauge syringe rapidly five to six 
times. The mixture was centrifuged at 13, 000  
g at 4 °C for 45 min, followed by further 
centrifugation for 15 min, and total protein extract 
was obtained. 
 
The protein concentration was determined by the 
Bradford assay [12], and ~ 100 μg samples were 
subjected to SDS-polyacrylamide gel 
electrophoresis. For TNF-α and COX-2, gels 
were transferred to polyvinylidene difluoride 
membranes (Millipore), and for COX-1, gels were 
transferred to nitrocellulose membranes using an 
immunoblotting apparatus (Bio-Rad). Next, 
membranes were blocked in 2 % skim milk in 
(Tris-buffered saline (TBS) containing 0.1 % 
Tween 20 for 60 min at room temperature. 
Membranes were further incubated overnight at 4 
°C with a rabbit monoclonal antibody (1: 1000 
v/v) against TNF-α, a mouse monoclonal 
antibody (1: 2000 v/v) against COX-1 and a 
rabbit polyclonal antibody (1:10000 v/v) against 
COX-2. The membranes were washed with 0.1 
% Tween-20 in TBS five to six times and then 
incubated with the appropriate horseradish 
peroxidase-conjugated secondary antibody (1: 
10000 v/v; Promega, USA). The immune 
complexes were visualised by ECL 
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chemiluminescence (GE Healthcare Life 
Sciences), and the intensities of the protein 
bands were quantified by image analysis. 
 
Molecular docking studies 
 
A molecular docking simulation of the 
interactions of the plant compounds and 
ibuprofen with TNF-α (PDB ID: 2TNFR), COX-1 
(PDB ID: 3N8X) and COX-2 (PDB ID: 6COX) 
was performed. First, the two-dimensional 
structures of kaempferol, myricetin, fisetin and 
ibuprofen were generated using ChemOffice 
2010, and their geometries were optimised and 
converted into 3D format [13]. The optimised 3D 
structures of these compounds were loaded into 
MVD [Molegro Virtual Docker 6.0], and their bond 
flexibility was determined. The potential ligand 
bindings of TNF-α (PDB ID: 2TNFR), COX-1 
(PDB ID: 3N8X) and COX-2 (PDB ID: 6COX) 
were predicted using MVD 5.0 [14].  
 
The ligand-binding site was detected by creating 
a grid with a resolution of 0.8 Å, which was 
placed in a 1.4-Å-radius sphere. Next, whether 
the sphere overlaps the Van der Waals radii of 
the protein atoms was assessed. Then, whether 
each accessible grid point belonged to the same 
cavity was determined. Finally, connected 
regions were identified, and the cavities identified 
were ranked according to volume [14]. The 
RMSD threshold for multiple cluster poses was 
set at 2.00 Å. An iteration of 1, 500 was set as 
the maximum for the docking algorithm with a 
simplex evolution size of 50. The docking engine 
was run for at least 30 docking simulations, and 




ADME toxicity analysis of kaempferol, fisetin, 
myricetin and ibuprofen was performed using 
ACD/I-Lab 2.0 [Advanced Chemistry 
Development, Canada] [15]. The absorption, 
distribution, bioavailability and LD50 values were 
calculated, and a comparative analysis of the 




The results of this study showed that the plant 
compounds kaempferol, fisetin and myricetin 
inhibited COX-1, COX-2 and TNF-α. The 
inhibition of COX-1, COX-2 and TNF-α by 
kaempferol, fisetin and myricetin 70 – 88 %) was 
greater than that by ibuprofen (57–64%) 
(Figure 1a‒c). Kaempferol (82 %) exerted the 
greatest inhibitory effect against TNF-α, followed 
by fisetin (74 %), myricetin (70 %) and ibuprofen 






Figure 1: Effects of plant compounds and ibuprofen 
on the expression level of (a) TNF-α, (b) COX-1 and(c) 
COX-2, determined by Western blotting. The 
densitometric analysis is obtained from the 
quantitative data which were scanned through X-ray 
films and further normalized to β-actin immunoblots () 
which are internal standard and represented as the 
relative density. 
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the greatest inhibitory effect against COX-1, 
followed by myricetin (79 %), fisetin (76 %) and 
ibuprofen (57 %) (Figure 1b). Fisetin (82 %) 
exerted the greatest inhibitory effect against 
COX-2 (88 %), followed by myricetin (83 %), 
kaempferol (75 %) and ibuprofen (71 %) (Fig. 
1c). The molecular docking scores based on the 
re-rank score, interaction energy and hydrogen 
bonding energy of kaempferol, myricetin, fisetin 
and ibuprofen with respect to TNF-α (PDB ID: 
2TNFR), COX-1 (PDB ID: 3N8X) and COX-2 
(PDB ID: 6COX) are shown in Table 2. 
Kaempferol, myricetin and fisetin inhibited the 
three proteins to a greater degree than did 
ibuprofen (Table 2). Images of the molecular 
interactions of these compounds with TNF-a, 
COX-1 and COX-2 are presented in Figure 2, 
Figure 3 and Figure 4, respectively.  
 
The ADME toxicity analysis indicated that the 
three plant compounds possess absorption and 
distribution properties similar to those of 
ibuprofen (Figure 5). Ibuprofen had a 
bioavailability of 70 %, compared with 30 % for 
the three plant compounds (Table 3). In addition, 
the three plant compounds exhibited LD50 values 




In the present investigation, myricetin, 
kaempferol and fisetin exerted inhibitory effects 
on COX-1, COX-2 and TNF-α, similar to the 
effects of ibuprofen.  
 
Treatment of rat pups with myricetin, kaempferol 
and fisetin reduced the hippocampal and total 
protein levels of COX-1, COX-2 and TNF-α 
significantly. In addition, fisetin and myricetin 
exerted similar inhibitory effects on TNF-α. 
Therefore, these plant compounds may be novel 
anti-inflammatory agents. 
 
Inhibition of TNF-α by the three plant compounds 
may be the result of their interaction with the 
hydroxyl groups (-OH) of the Arg32 and Asp143 
residues of TNF-α, which are bond donors that 
interact readily with the bond acceptors of 
kaempferol and fisetin, forming strong molecular 
interactions.  TNF-α is a cell signalling protein 
involved in inflammation that has been reported 
to be inhibited by flavonoids (epicatechin, 
quercetin and tiliroside) isolated from Waltheria 
indica [16]. Additionally, Nair et al. reported 
inhibition of TNF-α by the flavonoid quercetin 
[17]. The Gln203, Thr206 and Tyr385 residues of 
COX-1 undergo molecular interactions with 
myricetin, kaempferol and fisetin, likely via amine 
(-NH) and -OH functional groups. The frequency 
of using plant compounds to inhibit COX-1 has 
increased recently. Cao et al reported inhibition 
of COX-1 by compounds from traditional Chinese 
medicinal plants [18], and Momin et al reported 
inhibition of COX-1 by compounds isolated from 
Daucus carota [19]. The Met522 residue of COX-
2 interacts with myricetin, fisetin and kaempferol 
likely via the -NH and -OH groups of Met522. A 
variety of flavonoids, including quercetin, have 
been found to inhibit COX-2 [20]. 
 
The 4-6 -OH group of the plant compounds may 
also play a role in inhibition of COX-1, COX-2 
and TNF-α. This functional group readily forms a 
strong bond with the carbon atoms of proteins. 
Interestingly, the plants compounds used in this 
study are flavonoids possessing 80% structural 
similarity to quercetin, which is a potent inhibitor 
of COX-1 and COX-2. 
 
The results suggest that the three plant 
compounds may be more effective than 
ibuprofen because of their natural origin. These 
findings provide insight into the potential of 
myricetin, fisetin and kaempferol as therapeutic 
anti-inflammatory agents. 
 
The molecular docking score is based on the 
modified piecewise linear potential with new 
electrostatic and hydrogen bonding terms [21]. 
The top poses were considered based on the re-
rank score, which is a linear combination of the 
E-inter score (Van der Waals forces, hydrogen 
bonds, steric and electrostatic forces) between 
the protein and ligand, and the E-intra score (Van 
der Waals forces, hydrogen bonds, torsion and 
sp2-sp2 and electrostatic interactions) of the 
ligand weighted by pre-defined coefficients, as 
described by Thomsen and Christensen [21]. 
 
Myricetin, fisetin and kaempferol formed strong 
bonds and interactions with the ligand-binding 
sites of TNF-α, COX-1 and COX-2. The results 
demonstrated that myricetin, fisetin and 
kaempferol suppressed the enzymes responsible 
for inflammation. 
 
Moreover, ADME toxicity analysis revealed that 
the three plant compounds have pharmacological 
parameters superior to those of ibuprofen. 
Therefore, myricetin, fisetin and kaempferol can 
be used as alternatives to existing NSAIDs, 
which have several health-related side effects. 
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TNF-α (PDB ID: 2TNFR) Ligand COX-1 (PDB ID: 3N8X) Ligand COX-2 (PDB ID: 6COX) 
Rerank 
score Interaction HBond 
Rerank 
Score Interaction HBond 
Rerank 
score Interaction HBond 
Kaempferol  -72.71 -100.08 -5.59 Myricetin -110.39 -156.15 -7.31 Myricetin -98.34 -150.72 -15.10 
Fisetin -71.51 -110.97 -5.54 Kaempferol -103.01 -147.49 -5.23 Fisetin -92.45 -139.17 -9.68 
Myricetin -70.48 -109.84 -3.89 Fisetin -102.99 -146.52 -6.57 Kaempferol -88.94 -135.41 -6.74 
Ibuprofen -65.05 -111.53 -8.34 Ibuprofen -91.97 -121.06 -1.70 Ibuprofen -76.92 -103.44 -5.10 
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a                                                     b                                                        c 
Figure 2: Molecular interaction of TNF-α with (a) kaemferol: Agr32, Ala18, Val150, Ser147 and Asp143 (b) 
fisetin: Arg 32, Ala 145 and Asp143 (c) myricetin: Asn34 and Phe144 
 
 
          
a                                                       b                                                      c 
Figure 3: Molecular interaction of COX-1 with (a) myricetin: Tyr385, Thr 206, Ala199 and Gln203 (b) kaempferol: 
Gln203, Ala199, Tyr385, Thr206, His386 and Asn382 (c) fisetin: His386, Trp387, Gln203, Ala199, Thr206 and 
Tyr385 
 
              
a                                                       b                                                      c 
Figure 4: Molecular interaction of COX -2 with (a) myricetin: Ser530, Gly526, Met522, Ser353, His90, Tyr355, 
Gln192, Ile517 and Phe518 (b) fisetin: Met522, His90, Phe518 and Gln192 (c) kaempferol: Ser530, Met522 and 
His90. 
 
Table 3: ADME-toxicity for plant compounds and ibuprofen 
 
Parameter Fisetin Kaempferol Myricetin Ibuprofen 
Bioavailability (%) >30 >30 >30 70 
Absorption (%) 100 100 95 100 
Distribution(L/kg) 0.6 0.61 0.59 0.17 
LD50mouse(intraperitoneal), mg/kg  250 350 650 800 
LD50mouse (oral), mg/kg 1700 1000 800 1100 
LD50mouse (intravenous), mg/kg, 200 490 370 270 
LD50mouse (subcutaneous), mg/kg 400 410 120 690 
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The findings of this study indicate that myricetin, 
kaempferol and fisetin possess strong anti-
inflammatory activities. These plant compounds 
also exhibit enhanced pharmacological 
parameters and thus can be used as alternatives 
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